489 related articles for article (PubMed ID: 28802578)
1. Purification of functional reprogramming factors in mammalian cell using FLAG -Tag.
Han MJ; Kim HR; O'Reilly C; Kim CH
Biochem Biophys Res Commun; 2017 Oct; 492(2):154-160. PubMed ID: 28802578
[TBL] [Abstract][Full Text] [Related]
2. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
[TBL] [Abstract][Full Text] [Related]
3. Efficient RNA-Based Reprogramming of Disease-Associated Primary Human Fibroblasts into Induced Pluripotent Stem Cells.
McGrath PS; McGarvey SS; Kogut I; Bilousova G
Methods Mol Biol; 2020; 2117():271-284. PubMed ID: 31960386
[TBL] [Abstract][Full Text] [Related]
4. mRNA Reprogramming of T8993G Leigh's Syndrome Fibroblast Cells to Create Induced Pluripotent Stem Cell Models for Mitochondrial Disorders.
Grace HE; Galdun P; Lesnefsky EJ; West FD; Iyer S
Stem Cells Dev; 2019 Jul; 28(13):846-859. PubMed ID: 31017045
[TBL] [Abstract][Full Text] [Related]
5. Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.
Drozd AM; Walczak MP; Piaskowski S; Stoczynska-Fidelus E; Rieske P; Grzela DP
Stem Cell Res Ther; 2015 Jun; 6(1):122. PubMed ID: 26088261
[TBL] [Abstract][Full Text] [Related]
6. Stiffness of Hydrogels Regulates Cellular Reprogramming Efficiency Through Mesenchymal-to-Epithelial Transition and Stemness Markers.
Choi B; Park KS; Kim JH; Ko KW; Kim JS; Han DK; Lee SH
Macromol Biosci; 2016 Feb; 16(2):199-206. PubMed ID: 26439948
[TBL] [Abstract][Full Text] [Related]
7. The piggyBac Transposon as a Platform Technology for Somatic Cell Reprogramming Studies in Mouse.
Woltjen K; Kim SI; Nagy A
Methods Mol Biol; 2016; 1357():1-22. PubMed ID: 26126450
[TBL] [Abstract][Full Text] [Related]
8. Ectopic hTERT expression facilitates reprograming of fibroblasts derived from patients with Werner syndrome as a WS cellular model.
Wang S; Liu Z; Ye Y; Li B; Liu T; Zhang W; Liu GH; Zhang YA; Qu J; Xu D; Chen Z
Cell Death Dis; 2018 Sep; 9(9):923. PubMed ID: 30206203
[TBL] [Abstract][Full Text] [Related]
9. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
Heng BC; Fussenegger M
Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
[TBL] [Abstract][Full Text] [Related]
10. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells.
Park SJ; Lee SA; Prasain N; Bae D; Kang H; Ha T; Kim JS; Hong KS; Mantel C; Moon SH; Broxmeyer HE; Lee MR
Stem Cells Dev; 2017 May; 26(10):734-742. PubMed ID: 28346802
[TBL] [Abstract][Full Text] [Related]
11. Synthetic mRNA Reprogramming of Human Fibroblast Cells.
Liu J; Verma PJ
Methods Mol Biol; 2015; 1330():17-28. PubMed ID: 26621585
[TBL] [Abstract][Full Text] [Related]
12. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
[TBL] [Abstract][Full Text] [Related]
13. Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells with Sleeping Beauty Transposon-Based Stable Gene Delivery.
Sebe A; Ivics Z
Methods Mol Biol; 2016; 1400():419-27. PubMed ID: 26895068
[TBL] [Abstract][Full Text] [Related]
14. Using Oct4:MerCreMer Lineage Tracing to Monitor Endogenous Oct4 Expression During the Reprogramming of Fibroblasts into Induced Pluripotent Stem Cells (iPSCs).
Greder LV; Post J; Dutton JR
Methods Mol Biol; 2016; 1357():97-110. PubMed ID: 25687297
[TBL] [Abstract][Full Text] [Related]
15. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
[TBL] [Abstract][Full Text] [Related]
16. A Comparative View on Easy to Deploy non-Integrating Methods for Patient-Specific iPSC Production.
Manzini S; Viiri LE; Marttila S; Aalto-Setälä K
Stem Cell Rev Rep; 2015 Dec; 11(6):900-8. PubMed ID: 26341105
[TBL] [Abstract][Full Text] [Related]
17. Reactivation of Endogenous Genes and Epigenetic Remodeling Are Barriers for Generating Transgene-Free Induced Pluripotent Stem Cells in Pig.
Choi KH; Park JK; Son D; Hwang JY; Lee DK; Ka H; Park J; Lee CK
PLoS One; 2016; 11(6):e0158046. PubMed ID: 27336671
[TBL] [Abstract][Full Text] [Related]
18. Induced Pluripotent Stem Cells: Generation, Characterization, and Differentiation--Methods and Protocols.
Graversen VK; Chavala SH
Methods Mol Biol; 2016; 1357():395-401. PubMed ID: 25403469
[TBL] [Abstract][Full Text] [Related]
19. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
[TBL] [Abstract][Full Text] [Related]
20. Enhancing Induced Pluripotent Stem Cell Generation by MicroRNA.
Dang J; Rana TM
Methods Mol Biol; 2016; 1357():71-84. PubMed ID: 25687299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
